Osaic Holdings
PBMWW

Osaic Holdings’s Psyence Biomedical Warrant PBMWW Stock Holding History

Osaic Holdings’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$2K – 8089
2025
Q4 		$2K Hold
100,000
– – ﹤0.01% 7097
2025
Q3 		$2K Buy
+100,000
New +$2.52K ﹤0.01% 7130

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Osaic Holdings's PBMWW Position: Q1 2026 in Review

Osaic Holdings sold out of Psyence Biomedical Warrant (PBMWW) in Q1 2026, closing a stake of 100,000 shares — an estimated $2K sold.

Osaic Holdings first reported a position in PBMWW in Q3 2025 and held it in 2 quarters. The position peaked at $2K in Q4 2025. 19 funds tracked by Wall St. Rank hold PBMWW as of Q1 2026.

  • Osaic Holdings reported no remaining Psyence Biomedical Warrant position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 100,000 Psyence Biomedical Warrant shares in Q1 2026, an estimated $2K.
  • Osaic Holdings first reported a position in Psyence Biomedical Warrant in Q3 2025 and held it in 2 quarters.
  • Osaic Holdings's Psyence Biomedical Warrant position peaked at $2K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.